{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T04:03:05Z","timestamp":1747713785083,"version":"3.40.5"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Care Management Science"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1023\/a:1011838211092","type":"journal-article","created":{"date-parts":[[2002,12,23]],"date-time":"2002-12-23T11:26:45Z","timestamp":1040642805000},"page":"269-279","source":"Crossref","is-referenced-by-count":2,"title":["Prevention of Coronary Heart Disease through Treatment of Infection with Chlamydia Pneumoniae? Estimation of Possible Effectiveness and Costs"],"prefix":"10.1007","volume":"4","author":[{"given":"Colin","family":"Sanderson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Kubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"357200_CR1","volume-title":"Mortality statistics: cause 1993 (revised) and 1994","author":"Office for National Statistics","year":"1995","unstructured":"Office for National Statistics: Mortality statistics: cause 1993 (revised) and 1994, London HMSO (1995)."},{"key":"357200_CR2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1086\/514570","volume":"26","author":"K.J. Mattila","year":"1998","unstructured":"K.J. Mattila, V.V. Valtonen, M.S. Nieminen et al., Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke, Clinical Infectious Diseases 26 (1998) 719\u2013734.","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"357200_CR3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.1992.03490010070032","volume":"268","author":"D.H. Thom","year":"1992","unstructured":"D.H. Thom, J.T. Grayston, D.S. Siscovick, S.P. Wang, N.S. Weiss and J.R. Daling, Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease, Journal of the American Medical Association 268(1) (1992) 68\u201372.","journal-title":"Journal of the American Medical Association"},{"key":"357200_CR4","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/oxfordjournals.eurheartj.a014934","volume":"17","author":"H. Miettinen","year":"1996","unstructured":"H. Miettinen, S. Lehto, P. Saikku, S.M. Haffner, T. Ronnemaa, K. Pyroala and M. Laakso, Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland, European Heart Journal 17 (1996) 682\u2013688.","journal-title":"European Heart Journal"},{"key":"357200_CR5","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/infdis\/167.4.841","volume":"167","author":"C.C. Kuo","year":"1993","unstructured":"C.C. Kuo, A. Shor, L.A. Campbell, H. Fukushi, D.L. Patton and J.T. Grayston, Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries, Journal of Infectious Diseases 167 (1993) 841\u2013849.","journal-title":"Journal of Infectious Diseases"},{"key":"357200_CR6","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0735-1097(98)00016-3","volume":"31","author":"M. Maass","year":"1998","unstructured":"M. Maass, C. Bartels, P.M. Engel, U. Mamat and H.-H. Sievers, Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease, Journal of the American College of Cardiology 31 (1998) 827\u2013832.","journal-title":"Journal of the American College of Cardiology"},{"key":"357200_CR7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1378\/chest.112.2.309","volume":"112","author":"F. Blasi","year":"1997","unstructured":"F. Blasi, R. Cosentini, R. Raccanelli, F.M. Massari, C. Arosio et al., A possible association of Chlamydia pneumoniae infection and acute myocardial infarction in patients younger than 65 years of age, Chest 112 (1997) 309\u2013312.","journal-title":"Chest"},{"key":"357200_CR8","doi-asserted-by":"crossref","first-page":"S500","DOI":"10.1016\/S0002-8703(99)70285-1","volume":"138","author":"P. Saikku","year":"1999","unstructured":"P. Saikku, Epidemiology of Chlamydia pneumoniae in atherosclerosis, American Heart Journal 138 (1999) S500\u2013S503.","journal-title":"American Heart Journal"},{"key":"357200_CR9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0163-4453(92)91913-V","volume":"1","author":"P. Saikku","year":"1992","unstructured":"P. Saikku, The epidemiology and significance of Chlamydia pneumoniae, Journal of Infection 1 (1992) 27\u201334.","journal-title":"Journal of Infection"},{"key":"357200_CR10","first-page":"402","volume-title":"Chlamydial Infections","author":"S.-P. Wang","year":"1990","unstructured":"S.-P. Wang and J.T. Grayston, Population prevalence antibody to Chlamydia pneumoniae, strain TWAR, in: Chlamydial Infections, eds. W.R. Bowie, H.D. Caldwell, R.P. Jones et al. (Cambridge University Press, Cambridge, 1990) pp. 402\u2013405."},{"issue":"11","key":"357200_CR11","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1699-0463.1995.tb01436.x","volume":"103","author":"M.E. Ward","year":"1995","unstructured":"M.E. Ward, The immunobiology and immunopathology of chlamydial infections, APMIS 103(11) (1995) 769\u2013796.","journal-title":"APMIS"},{"key":"357200_CR12","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1161\/01.CIR.97.17.1669","volume":"97","author":"J.T. Grayston","year":"1998","unstructured":"J.T. Grayston, Antibiotic treatment of Chlamydia pneumoniae for secondary prevention of cardiovascular events, Circulation 97 (1998) 1669\u20131670.","journal-title":"Circulation"},{"issue":"3","key":"357200_CR13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0966-842X(94)90542-8","volume":"2","author":"W.L. Beatty","year":"1994","unstructured":"W.L. Beatty, G.I. Byrne and R.P. Morrison, Repeated and persistent infection with Chlamydia and the development of chronic in-flammation and disease, Trends in Microbiology 2(3) (1994) 94\u201398.","journal-title":"Trends in Microbiology"},{"key":"357200_CR14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/clinids\/14.1.178","volume":"14","author":"M.R. Hammerschlag","year":"1992","unstructured":"M.R. Hammerschlag, K. Chirgwin, P.M. Roblin, M. Gelling, W. Dumornay et al., Persistent infection with Chlamydia pneumoniae following acute respiratory illness, Clinical Infectious Diseases 14 (1992) 178\u2013182.","journal-title":"Clinical Infectious Diseases"},{"key":"357200_CR15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/01.CIR.96.2.404","volume":"96","author":"S. Gupta","year":"1997","unstructured":"S. Gupta, E.W. Leatham, D. Carrington, M.A. Mendall, J.C. Kaski and A.J. Camm, Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction, Circulation 96 (1997) 404\u2013407.","journal-title":"Circulation"},{"key":"357200_CR16","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0140-6736(97)07201-2","volume":"350","author":"E. Gurfinkel","year":"1997","unstructured":"E. Gurfinkel, G. Bozovich, A. Daroca, E. Beck and B. Mautner, For the Roxis study group, Randomised trial of roxithromycin in non-Qwave coronary syndromes: ROXIS pilot study, The Lancet 350 (1997) 404\u2013407.","journal-title":"The Lancet"},{"key":"357200_CR17","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1161\/01.CIR.99.12.1540","volume":"99","author":"J.L. Anderson","year":"1999","unstructured":"J.L. Anderson, J.B. M\u00fchlestein, J. Carlquist et al., Randomised secondary prevention trial of azithromycin in patients with coronary artery disease and serologic evidence for Chlamydia pneumoniae infection, Circulation 99 (1999) 1540\u20131547.","journal-title":"Circulation"},{"key":"357200_CR18","doi-asserted-by":"crossref","first-page":"S545","DOI":"10.1016\/S0002-8703(99)70298-X","volume":"138","author":"J.T. Grayston","year":"1999","unstructured":"J.T. Grayston, L.A. Jackson, W.J. Kennedy and R.A. Kronmal, Secondary prevention trials for coronary artery disease with antibiotic treatment for Chlamydia pneumoniae: Design issues, American Heart Journal 138 (1999) S545\u2013S549.","journal-title":"American Heart Journal"},{"key":"357200_CR19","doi-asserted-by":"crossref","first-page":"S542","DOI":"10.1016\/S0002-8703(99)70297-8","volume":"138","author":"M. Dunne","year":"1999","unstructured":"M. Dunne, WIZARD and the design of trials for secondary prevention of atherosclerosis with antibiotics, American Heart Journal 138 (1999) S542\u2013S544.","journal-title":"American Heart Journal"},{"key":"357200_CR20","volume-title":"Health Survey for England 1994","author":"H. Colhoun","year":"1996","unstructured":"H. Colhoun and P. Prescott-Clarke, Health Survey for England 1994, Department of Epidemiology and Public Health, University College London, London HMSO (1996)."},{"key":"357200_CR21","volume-title":"Health Survey for England 1993","author":"N. Bennett","year":"1995","unstructured":"N. Bennett, T. Dodd, J. Flatley, S. Freeth and K. Bolling, Health Survey for England 1993, Department of Epidemiology and Public Health, University College London, London HMSO (1995)."},{"key":"357200_CR22","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/hrt.51.6.595","volume":"51","author":"A.G. Shaper","year":"1984","unstructured":"A.G. Shaper, D.G. Cook, M. Walker and P.W. Macfarlane, Prevalence of ischaemic heart disease in middle aged British men, British Heart Journal 51 (1984) 595\u2013605.","journal-title":"British Heart Journal"},{"key":"357200_CR23","volume-title":"Morbidity Statistics from General Practice 1991\u20131992","author":"Royal College of General Practitioners","year":"1995","unstructured":"Royal College of General Practitioners, Morbidity Statistics from General Practice 1991\u20131992, London HMSO (1995)."},{"key":"357200_CR24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/jech.51.1.87","volume":"51","author":"A. Bottomley","year":"1997","unstructured":"A. Bottomley, Methodology for assessing the prevalence of angina in primary care using practice based information in northern England, Journal of Epidemiology and Community Health 51 (1997) 87\u201389.","journal-title":"Journal of Epidemiology and Community Health"},{"key":"357200_CR25","first-page":"1119","volume":"27","author":"J.L. Rouleau","year":"1996","unstructured":"J.L. Rouleau, M. Talajic, B. Sussex, L. Potvin, W. Warnica et al., Myocardial infarction patients in the 1990s \u2013 their risk factors, stratification and survival in Canada. The Canadian assessment of myocardial infarction (CAMI) study, Journal of the American College of Cardiology 27 (1996) 1119\u20131127.","journal-title":"The Canadian assessment of myocardial infarction (CAMI) study, Journal of the American College of Cardiology"},{"key":"357200_CR26","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/clc.4960190809","volume":"19","author":"J.A. Fournier","year":"1996","unstructured":"J.A. Fournier, A. Sanchez, J. Quero, J.A.P. Fernandez-Cortacero and A. Gonzalez-Barrero, Myocardial infarction in men aged 40 years or less: a prospective clinical-angiographic study, Clinical Cardiology 19 (1996) 631\u2013636.","journal-title":"Clinical Cardiology"},{"key":"357200_CR27","first-page":"1383","volume":"344","author":"Scandinavian Simvastatin Survival Study Group.","year":"1994","unstructured":"Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S), The Lancet 344 (1994) 1383\u20131389.","journal-title":"The Lancet"},{"key":"357200_CR28","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/0735-1097(91)90792-8","volume":"18","author":"J.J.M. De Vreede","year":"1991","unstructured":"J.J.M. De Vreede, A.P.M. Gorgels, G.M.P. Verstraaten et al., Did prognosis after acute myocardial infarction change during the past 30 years? A meta-analysis, Journal of the American College of Cardiology 18 (1991) 698\u2013706.","journal-title":"Journal of the American College of Cardiology"},{"issue":"14","key":"357200_CR29","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1056\/NEJM199604043341403","volume":"334","author":"P.G. McGovern","year":"1996","unstructured":"P.G. McGovern, J.S. Pankow, E. Shahar, K.M. Doliszny, A.R. Folsom et al., Recent trends in acute coronary heart disease. Mortality, morbidity, medical care, and risk factors, New England Journal of Medicine 334(14) (1996) 884\u2013890.","journal-title":"New England Journal of Medicine"},{"key":"357200_CR30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/bmj.307.6900.349","volume":"307","author":"R. Stevenson","year":"1993","unstructured":"R. Stevenson, K. Ranjadayalan, P. Wilkinson, R. Roberts and A.D. Timmis, Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis, British Medical Journal 307 (1993) 349\u2013353.","journal-title":"British Medical Journal"},{"key":"357200_CR31","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/hrt.74.6.604","volume":"74","author":"J.S. Skinner","year":"1995","unstructured":"J.S. Skinner, C.J. Albers, J. Goudevenos, C. Fraser, O. Odemuyiwa et al., Prospective study of patients aged 55 years or less with acute myocardial infarction between 1981 and 1985: outcome 7 years and beyond, British Heart Journal 74 (1995) 604\u2013610.","journal-title":"British Heart Journal"},{"key":"357200_CR32","volume-title":"The Framingham Study, Section 35: Survival following initial cardiovascular events, 30 year follow-up","author":"W.B. Kannel","year":"1988","unstructured":"W.B. Kannel, P.A. Wolf and R.J. Garrison, The Framingham Study, Section 35: Survival following initial cardiovascular events, 30 year follow-up (US Department of Commerce, National Technical Information Service, Springfield, IL, 1988)."},{"key":"357200_CR33","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1136\/bmj.316.7141.1337","volume":"316","author":"C. Baigent","year":"1998","unstructured":"C. Baigent, R. Collins, P. Appleby, S. Parish, P. Sleight and R. Peto, On behalf of the ISIS-2 Collaborative Group, Isis-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both or neither, British Medical Journal 316 (1998) 1337\u20131343.","journal-title":"British Medical Journal"},{"key":"357200_CR34","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.2105\/AJPH.77.11.1417","volume":"77","author":"M.C. Weinstein","year":"1987","unstructured":"M.C. Weinstein, P.G. Coxson, L.W. Williams, T.M. Pass, W.B. Stason and L. Goldman, Forecasting coronary heart disease incidence, mortality, and cost: The coronary heart disease policy model, American Journal of Public Health 77 (1987) 1417\u20131426.","journal-title":"American Journal of Public Health"},{"issue":"3","key":"357200_CR35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0002-9149(92)91294-E","volume":"69","author":"T.H. Lee","year":"1992","unstructured":"T.H. Lee, H.H. Ting, J.B. Shammash, J.R. Soukup and L. Goldman, Long-term survival of emergency department patients with acute chest pain, The American Journal of Cardiology 69(3) (1992) 145\u2013151.","journal-title":"The American Journal of Cardiology"},{"key":"357200_CR36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/ije\/24.1.58","volume":"24","author":"E. Sigurdsson","year":"1995","unstructured":"E. Sigurdsson, N. Sigfusson, U. Agnarsson, H. Sigvaldason and G. Thorgeirsson, Long-term prognosis of different forms of coronary heart disease: the Reykjavik study, International Journal of Epidemiology 24 (1995) 58\u201368.","journal-title":"International Journal of Epidemiology"},{"issue":"3","key":"357200_CR37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0146-2806(06)80025-3","volume":"20","author":"D.J. Moliterno","year":"1995","unstructured":"D.J. Moliterno, J.M. Elliott and E.J. Topol, Randomised trials of myocardial revascularization, Current Problems in Cardiology 20(3) (1995) 121\u2013152.","journal-title":"Current Problems in Cardiology"},{"key":"357200_CR38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/01.CIR.86.1.121","volume":"86","author":"The VA coronary artery bypass surgery cooperative study group","year":"1992","unstructured":"The VA coronary artery bypass surgery cooperative study group, Eighteen-year follow-up in the Veterans Affairs Cooperative study of coronary artery bypass surgery for stable angina, Circulation 86 (1992) 121\u2013130.","journal-title":"Circulation"},{"issue":"7","key":"357200_CR39","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/0735-1097(95)00395-9","volume":"26","author":"M. Tervahauta","year":"1995","unstructured":"M. Tervahauta, J. Pekkanen and A. Nissinen, Risk factors of coronary heart disease and total mortality among elderly men with and without preexisting coronary heart disease. Finish cohorts of the seven countries study, Journal of the American College of Cardiology 26(7) (1995) 1623\u20131629.","journal-title":"Journal of the American College of Cardiology"},{"key":"357200_CR40","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/hrt.73.2.193","volume":"73","author":"M.M. Gandhi","year":"1995","unstructured":"M.M. Gandhi, F.C. Lampe and D.A. Wood, Incidence, clinical characteristics, and short-term prognosis of angina pectoris, British Heart Journal 73 (1995) 193\u2013198.","journal-title":"British Heart Journal"},{"key":"357200_CR41","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0002-8703(91)90861-B","volume":"121","author":"K.M. Anderson","year":"1990","unstructured":"K.M. Anderson, P.M. Odell, P.W.F. Wilson and W.B. Kannel, Cardiovascular disease risk profiles, American Heart Journal 121 (1990) 293\u2013298.","journal-title":"American Heart Journal"},{"key":"357200_CR42","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/bmj.311.7007.711","volume":"311","author":"P. Patel","year":"1995","unstructured":"P. Patel, M.A. Mendall, D. Carrington, D.P. Strachan, E. Leatham et al., Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cariovascular risk factors, British Medical Journal 311 (1995) 711\u2013714.","journal-title":"British Medical Journal"},{"key":"357200_CR43","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/bmj.318.7190.1035","volume":"318","author":"D.P. Strachan","year":"1999","unstructured":"D.P. Strachan, D. Carrington, M.A. Mendall, L. Ballam, J. Morris et al., Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the Caerphilly prospective heart disease study, British Medical Journal 318 (1999) 1035\u20131040.","journal-title":"British Medical Journal"},{"key":"357200_CR44","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/bmj.317.7160.713","volume":"317","author":"The UK Prospective Diabetes Study Group","year":"1998","unstructured":"The UK Prospective Diabetes Study Group, Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39, British Medical Journal 317 (1998) 713\u2013720.","journal-title":"British Medical Journal"},{"unstructured":"Office of Health Economics. Health economics evaluations database 1995\u20131997 (OHE \u2013 IFPMA Database, Ltd., London).","key":"357200_CR45"},{"key":"357200_CR46","volume-title":"Unit Costs of Health & Social Care 1996","author":"A. Netten","year":"1996","unstructured":"A. Netten and J. Dennett, Unit Costs of Health & Social Care 1996 (PSSRU at University of Kent, Canterbury, 1996)."},{"unstructured":"British Medical Association and Royal Pharmaceutical Society of Great Britain (British National Formulary, London, 1999).","key":"357200_CR47"},{"issue":"1","key":"357200_CR48","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2165\/00019053-199712020-00008","volume":"12","author":"S. Hummel","year":"1997","unstructured":"S. Hummel, J. Piercy, R. Wright, A. Davie, A. Bagust and J. McMurray, An economic analysis of the survival and ventricular enlargement (SAVE) study, Pharmacoeconomics 12(1, 2) (1997) 182\u2013192.","journal-title":"Pharmacoeconomics"},{"key":"357200_CR49","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/oxfordjournals.eurheartj.a015466","volume":"18","author":"J.J.V. McMurray","year":"1997","unstructured":"J.J.V. McMurray, A. McGuire, A.P. Davie and D. Hughes, Costeffectiveness of different ACE inhibitor treatment scenarios postmyocardial infarction, European Heart Journal 18 (1997) 1411\u20131415.","journal-title":"European Heart Journal"},{"unstructured":"Unpublished data, Medtap, London (1997).","key":"357200_CR50"},{"unstructured":"Hospital Cost Input Inflation, NHS Executive, Finance Directorate, Leeds.","key":"357200_CR51"},{"doi-asserted-by":"crossref","unstructured":"J.A. Cairns and M.M. van der Pol, The estimation of marginal time preference in a UK-wide sample, Health Technology Assessment 4 (2000).","key":"357200_CR52","DOI":"10.3310\/hta4010"},{"key":"357200_CR53","volume-title":"Coronary Heart Disease Epidemiology: From Aetiology to Public Health","author":"M. Marmot","year":"1992","unstructured":"M. Marmot and P. Elliott, Coronary Heart Disease Epidemiology: From Aetiology to Public Health (Oxford University Press, Oxford, 1992)."},{"key":"357200_CR54","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/bmj.311.7001.351","volume":"311","author":"J. Fletcher","year":"1995","unstructured":"J. Fletcher, N.R. Hicks, J.D.S. Kay and P.A. Boyd, Using decision analysis to compare policies for antenatal screening for Down's syndrome, British Medical Journal 311 (1995) 351\u2013356.","journal-title":"British Medical Journal"},{"issue":"4","key":"357200_CR55","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3109\/14639239109067657","volume":"16","author":"M. Johannesson","year":"1991","unstructured":"M. Johannesson, J. Hedbrant and B. Jonsson, A computer simulation model for cost-effectiveness analysis of cardiovascular disease prevention, Medical Informatics 16(4) (1991) 355\u2013362.","journal-title":"Medical Informatics"},{"key":"357200_CR56","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1056\/NEJM199701303360503","volume":"336","author":"M. Johannesson","year":"1997","unstructured":"M. Johannesson, B. Jonsson, J. Kjekshus, Olsson et al., For the Scandinavian simvastatin survival study group, Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease, New England Journal of Medicine 336 (1997) 332\u2013336.","journal-title":"New England Journal of Medicine"},{"key":"357200_CR57","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/hrt.82.3.325","volume":"82","author":"D.M. Pickin","year":"1999","unstructured":"D.M. Pickin, C.J. McCabe, L.E. Ramsay, N. Payne, I.U. Haq et al., Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment, Heart 82 (1999) 325\u2013332.","journal-title":"Heart"},{"key":"357200_CR58","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1136\/bmj.312.7041.1274","volume":"312","author":"D. Wonderling","year":"1996","unstructured":"D. Wonderling, S. Langham, M. Buxton, C. Normand, C. McDermott et al., What can be concluded from the Oxcheck and British family heart studies: Commentary on cost-effectiveness analyses, British Medical Journal 312 (1996) 1274\u20131278.","journal-title":"British Medical Journal"},{"doi-asserted-by":"crossref","unstructured":"S. Ebrahim, G. Davey Smith, C. McCabe et al., What role for statins? A review and economic model, Health Technology Assessment 3(19) (1999).","key":"357200_CR59","DOI":"10.3310\/hta3190"},{"doi-asserted-by":"crossref","unstructured":"J. Cuzick, P. Sasieni, P. Davies et al., Systematic review of the role of human papilloma virus within a cervical screening programme, Health Technology Assessment 3(14) (1999).","key":"357200_CR60","DOI":"10.3310\/hta3140"}],"container-title":["Health Care Management Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1011838211092.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1011838211092\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1011838211092.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T10:53:39Z","timestamp":1747652019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1011838211092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["357200"],"URL":"https:\/\/doi.org\/10.1023\/a:1011838211092","relation":{},"ISSN":["1386-9620","1572-9389"],"issn-type":[{"type":"print","value":"1386-9620"},{"type":"electronic","value":"1572-9389"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}